Sanders Morris Harris’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $480K | Sell |
1,908
-18,921
| -91% | -$4.07M | 0.28% | 41 |
|
|
2026
Q1 | $4.53M | Buy |
+20,829
| New | +$4.62M | 0.72% | 28 |
|
|
2025
Q4 | – | Sell |
-21,512
| Closed | -$4.98M | – | 37 |
|
|
2025
Q3 | $4.98M | Buy |
21,512
+18,639
| +649% | +$3.8M | 0.66% | 24 |
|
|
2025
Q2 | $533K | Sell |
2,873
-19,558
| -87% | -$3.63M | 0.13% | 67 |
|
|
2025
Q1 | $4.64M | Sell |
22,431
-100
| -0.4% | -$19.4K | 0.72% | 23 |
|
|
2024
Q4 | $4M | Sell |
22,531
-300
| -1% | -$55.2K | 0.6% | 27 |
|
|
2024
Q3 | $4.51M | Sell |
22,831
-60
| -0.3% | -$11.2K | 0.75% | 20 |
|
|
2024
Q2 | $3.93M | Hold |
22,891
| – | – | 0.64% | 32 |
|
|
2024
Q1 | $4.17M | Buy |
22,891
+3,393
| +17% | +$585K | 0.77% | 22 |
|
|
2023
Q4 | $3.13M | Sell |
19,498
-3,598
| -16% | -$525K | 1.54% | 14 |
|
|
2023
Q3 | $3.41M | Hold |
23,096
| – | – | 0.7% | 22 |
|
|
2023
Q2 | $3.12M | Buy |
23,096
+19,498
| +542% | +$2.86M | 0.69% | 20 |
|
|
2023
Q1 | $573K | Sell |
3,598
-19,498
| -84% | -$2.98M | 0.2% | 46 |
|
|
2022
Q4 | $3.73M | Hold |
23,096
| – | – | 1.41% | 11 |
|
|
2022
Q3 | $3.18M | Sell |
23,096
-62
| -0.3% | -$8.9K | 0.78% | 23 |
|
|
2022
Q2 | $3.56M | Hold |
23,158
| – | – | 0.78% | 26 |
|
|
2022
Q1 | $3.75M | Buy |
23,158
+62
| +0.3% | +$9.01K | 0.73% | 25 |
|
|
2021
Q4 | $3.11M | Hold |
23,096
| – | – | 0.54% | 33 |
|
|
2021
Q3 | $2.55M | Sell |
23,096
-160
| -0.7% | -$18.3K | 0.46% | 41 |
|
|
2021
Q2 | $2.68M | Buy |
23,256
+160
| +0.7% | +$18K | 0.52% | 40 |
|
|
2021
Q1 | $2.44M | Buy |
23,096
+598
| +3% | +$64K | 0.52% | 42 |
|
|
2020
Q4 | $2.51M | Hold |
22,498
| – | – | 0.57% | 42 |
|
|
2020
Q3 | $1.97M | Buy |
22,498
+9,358
| +71% | +$881K | 0.54% | 41 |
|
|
2020
Q2 | $1.3M | Buy |
13,140
+5,738
| +78% | +$505K | 0.63% | 27 |
|
|
2020
Q1 | $328K | Sell |
7,402
-19,378
| -72% | -$1.65M | 0.32% | 75 |
|
|
2019
Q4 | $2.39M | Sell |
26,780
-1,850
| -6% | -$154K | 0.54% | 46 |
|
|
2019
Q3 | $2.07M | Buy |
28,630
+1,400
| +5% | +$96K | 0.5% | 49 |
|
|
2019
Q2 | $1.99M | Buy |
+27,230
| New | +$2.14M | 0.52% | 45 |
|
|
2016
Q2 | – | Sell |
-17,566
| Closed | -$1M | – | 241 |
|
|
2016
Q1 | $1M | Buy |
+17,566
| New | +$979K | 0.17% | 119 |
|
Other funds holding ABBV
Sanders Morris Harris's ABBV Position: Q2 2026 in Review
Sanders Morris Harris reduced its AbbVie (ABBV) stake by 91% in Q2 2026, selling an estimated $4.07M and leaving 1,908 shares worth $480K. The position accounts for 0.28% of the portfolio, ranked #41.
Sanders Morris Harris first reported a position in ABBV in Q1 2016 and has held it in 29 quarters since. The position peaked at $4.98M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sanders Morris Harris held 1,908 shares of AbbVie worth $480K as of Q2 2026.
- Sanders Morris Harris sold 18,921 AbbVie shares in Q2 2026, an estimated $4.07M.
- AbbVie made up 0.28% of Sanders Morris Harris's portfolio in Q2 2026, its #41 holding.
- Sanders Morris Harris first reported a position in AbbVie in Q1 2016 and has held it in 29 quarters since.
- Sanders Morris Harris's AbbVie position peaked at $4.98M in Q3 2025.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.